Shriprakash Pharma Private Limited
About Shriprakash Pharma Private Limited
Data last updated:
Shriprakash Pharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 14 June 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24231UP1994PTC016551. Its GSTIN is 09AAOFS0807K1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.01 Lakh. It is led by directors including Priyanka Gupta and Manish Chandra Gupta.
Its last annual general meeting (AGM) was held on 27 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 64 W – 2 Juhi Kalan, Kanpur, Uttar Pradesh, India – 208027.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.9 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹22,164 (net margin 0.5%) and EBITDA of ₹22,535 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shriprakash Pharma Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address64 W – 2 Juhi Kalan, Kanpur, Uttar Pradesh, India – 208027
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Shriprakash Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shriprakash Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shriprakash Pharma Private Limited, buy the company report.
Financials of Shriprakash Pharma Private Limited
FY 2025 filings availableShriprakash Pharma Private Limited reported revenue of ₹46.9 Lakh (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 20% growth in the latest year. EBITDA rose 313% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,535 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22,164 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shriprakash Pharma Private Limited, buy the company report.
Board of directors of Shriprakash Pharma Private Limited
Shriprakash Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priyanka Gupta | Director | 15 Jan 2021 | 5 Years 9 Months | Current |
| Manish Chandra Gupta | Director | 15 Jan 2021 | 5 Years 9 Months | Current |
| Gayatri Devi Gupta | Director | 14 Jun 1994 | 32 Years 4 Months | Current |
| Girish Chandra Gupta | Director | 08 Mar 2009 | 17 Years 7 Months | Current |
Peer comparison
Shriprakash Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fringe Biotech Private Limited | ₹46.93 Lakh (FY 2025) | 24.0% | Gmc, Assam, India | |||
| Indaf Industries Limited | ₹46.92 Lakh (FY 2025) | 17.0% | Lucknow, Uttar Pradesh, India | |||
| G.N. Silk Estate Private Limited | ₹46.91 Lakh (FY 2024) | -69.0% | Bangalore, Karnataka, India | |||
| Sri Vipula Agritech Private Limited | ₹46.91 Lakh (FY 2016) | 1217.0% | Hyderabad, Telangana, India | |||
| RSJ Consumer Products Private Limited | ₹46.9 Lakh (FY 2015) | 21.0% | New Delhi, Delhi, India | |||
| Shriprakash Pharma Private Limitedthis company | ₹46.9 Lakh (FY 2025) | ₹22,164 | 0.5% | 20.0% | Kanpur, Uttar Pradesh, India | |
| Adishree Commercial Private Limited | ₹46.89 Lakh (FY 2025) | -11.0% | Kolkata, West Bengal, India | |||
| Gayathri Geotech Private Limited | ₹46.89 Lakh (FY 2025) | -18.0% | Nelamangala, Karnataka, India | |||
| Euglow Pharma Limited | ₹46.89 Lakh (FY 2020) | -3.0% | Thanjavur, Tamil Nadu, India | |||
| Galore Sales & Services India Private Limited | ₹46.88 Lakh (FY 2022) | -24.0% | New Delhi, Delhi, India | |||
| Xaastag Regtech Private Limited | ₹46.88 Lakh (FY 2021) | 26421.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Shriprakash Pharma Private Limited, buy the company report.
Auditor
Shriprakash Pharma Private Limited is audited by ANUPAM K BANSAL AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUPAM K BANSAL AND CO | FY 2017 | 071888 |
Shareholding
The shareholding of Shriprakash Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Shriprakash Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shriprakash Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shriprakash Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shriprakash Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAOFS0807K1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shriprakash Pharma Private Limited, buy the company report.
Recent activity
Shriprakash Pharma Private Limited has 6 board changes on record since 1994: 4 appointments and 2 cessations. The latest: Manish Chandra Gupta was appointed as Director on 15 Jan 2021.
Frequently asked questions
Shriprakash Pharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 14 June 1994 (32+ years old) and is registered under CIN U24231UP1994PTC016551.
Shriprakash Pharma has 4 current directors:
- Priyanka Gupta - Director
- Manish Chandra Gupta - Director
- Gayatri Devi Gupta - Director
- Girish Chandra Gupta - Director
The latest financial statements of Shriprakash Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shriprakash Pharma is 09AAOFS0807K1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Shriprakash Pharma is U24231UP1994PTC016551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shriprakash Pharma was incorporated on 14 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Shriprakash Pharma by revenue are Fringe Biotech Private Limited, Indaf Industries Limited, G.N. Silk Estate Private Limited, Sri Vipula Agritech Private Limited, RSJ Consumer Products Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Manish Chandra Gupta was appointed as Director on 15 Jan 2021. Priyanka Gupta was appointed as Director on 15 Jan 2021. Satish Chandra Gupta ceased to be Director on 25 Jun 2020. Shriprakash Pharma has 6 board changes on record in total.
The registered office of Shriprakash Pharma is at 64 W – 2 Juhi Kalan, Kanpur, Uttar Pradesh, India – 208027.
Shriprakash Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Shriprakash Pharma is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.